Search filters

Filters
Clear All

Phase

  • 59
  • 97
  • 108
  • 89
  • 14
  • 169
  • 697
  • 454
  • 14
  • 32
  • 1
  • 4
  • 648

Found 699 none trials

A listing of none medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

99 years or below
All genders
Phase 2
The purpose of this research study is to measure the safety of BST-236 and how effective it is in treating patients with newly-diagnosed acute myeloid leukemia (AML) who are not eligible for standard induction chemotherapy.
99 years or below
All genders
Phase 3
The study is an open-label, randomized, parallel group study conducted in patients with histologically confirmed MPM of epithelioid or biphasic (predominantly [50%] epithelioid) histology who have failed a minimum of 1 treatment regimen and a maximum of 2 treatment regimens, 1 of which must have been an anti-folate and platinum …
 Featured trial 3
Female
Testing ggggggggggggggggggggggggggggggggggggggggg
 A Phase III  multi-center  double-blind  randomized withdrawal study of LCI699 following a 24 week  single-arm  open-label dose titration and treatment period to evaluate the safety and efficacy of LCI699 for the treatment of patients with Cushings disease (PRIME)
1 years - 99 years
All genders
Phase 3
The study aims to confirm the long-term efficacy and safety of LCI699 for the treatment of patients with Cushing's disease who have had had surgery that has not been successful, or are not a good surgical candidate, or refuse surgery, and have not received radiation treatment for this condition within …
 UPCC 35217: A Phase 1B/2  Open label study of Niraparib plus either Ipilimumab or Nivolumab in patients with advanced Pancreatic Cancer who have achieved stability on platinum- based therapy
99 years or below
All genders
Phase 2
The main purpose of this study is to look at the effectiveness, safety, and anti-tumor activity (preventing growth of the tumor) of the drugs niraparib with either ipilimumab or nivolumab on patients and their pancreatic cancer.
 EFICACIA Y SEGURIDAD DE UN MEDICAMENTO INYECTABLE UNA VEZ A LA SEMANA EN PARTICIPANTES CON SOBREPESO U OBESIDAD. (REDEFINIR 1)
1 years - 99 years
All genders
Phase 3
Este es un estudio de prueba de concepto multicéntrico, aleatorizado, doble ciego, controlado con placebo, de 2 brazos, de grupos paralelos. El objetivo principal de este estudio es evaluar el efecto de dupilumab en el alivio de los síntomas clínicos de la EoE y la reducción de la inflamación esofágica …
 Randomized Controlled Trial Examining the Effects of Meal Timing Among Obese Individuals
21 years - 50 years
All genders
Normal 0 false false false EN-US X-NONE X-NONE We are currently screening for this study, but all in-person visits are on hold until the COVID-19 virus state of emergency is lifted. The timing of food consumption is now recognized as a significant contributor to body weight regulation and metabolic functioning. …
 A Phase 2B Prospective  Randomized  Double-blinded  Placebo-controlled Clinical Study Demonstrating the Efficacy and Safety of Rebiotix RBX2660 (microbiota suspension) for the Treatment of Recurrent Clostridium difficile Infection
1 years - 99 years
All genders
Phase 2
Rebiotix Incs RBX2660 (microbiota suspension) is an intestinal microbial suspension intended to treat recurrent Clostridium difficile infection (CDI). RBX2660 is administered via enema and is for rectal use only. Administration of similar products, commonly known as fecal transplants (FT), have documented significant clinical evidence of safe and effective use for …
 IMAGING OF IN VIVO SIGMA-2 RECEPTOR EXPRESSION WITH [18F]ISO-1 POSITRON EMISSION TOMOGRAPHY (PET/CT) IN METASTATIC BREAST CANCER
18 years - 80 years
Female
Patients with metastatic breast cancer, that is biopsy proven or clinically documented by standard imaging (e.g. CT, MRI, Bone Scan, Ultrasound, FDG PET/CT), may be eligible for this study.  Patients may participate in this study, if they are at least 18 years of age.  We anticipate enrolling up to 30 …
 Effects of Insomnia Treatment on Metabolism in Patients with Depression
21 years - 60 years
All genders
800x600 Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 Are you currently depressed and have trouble sleeping? Are you between the ages of 21 and 60? You may be eligible for one of our current research studies:Cognitive behavioral therapy for insomnia (CBT-I) has been the ‘gold standard’ for the …
351 - 360 of 699